×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Articles

Kristie L. Kahl
From celebrity news to a new partnership aimed to help patients and their caregivers, here’s what is making headlines in the cancer space this week.
Jessica Skarzynski
Once you try this week’s #CURESummerSnacktime recipe for Peanut Butter Banana Ice Cream, we bet you’ll be adding this cool, creamy concoction into your weekly rotation.
Jessica Skarzynski
In a new study, Zejula (niraparib) has been shown to prolong life for patients with ovarian cancer who have already undergone four or more rounds of chemotherapy.
Katie Kosko
A nearly 10-year stomach cancer survivor works with Debbie’s Dream Foundation to raise disease awareness and raise money for a cure.
Kristie L. Kahl
Patients whose cancers have the NTRK gene fusion as well as those with ROS1-positive non-small cell lung cancer now have a second targeted therapy as a treatment option.
Kristie L. Kahl
After almost a decade with no new treatments, Inrebic offers patients with myelofibrosis new hope for the future.
Beth Fand Incollingo
When non-small cell lung cancer spreads to just a few sites, therapy can be given with curative intent – and immunotherapy can help delay relapse.
Kristie L. Kahl
Following its announcement of covering chimeric antigen receptor-T cell therapy nationwide, the Centers for Medicare and Medicaid Services has now made this highly-priced, but life-saving, treatment available to many who would not otherwise have access to it at their cancer centers.
Kristie L. Kahl
The Food and Drug Administration approved Inrebic as the first new treatment in nearly a decade for patients with myelofibrosis.
 
Katie Kosko
From an FDA warning to real-life superheroes, here’s what is making headlines in the cancer space this week.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×